Phil Stead

Phil Stead is a seasoned professional in the health technology and medical device sectors, currently serving as the Business Unit Leader for Early Intervention (Sports Medicine) at Johnson & Johnson MedTech since June 2025. Prior to this role, Phil held the position of Chief Growth Officer at Grouper, focusing on initiatives to combat social isolation among older adults. Phil's extensive experience includes over nine years at Bioventus, where responsibilities ranged from General Manager of Pain Treatment and Restorative Therapies to Vice President of US Sales, playing a crucial role in the company’s Initial Public Offering in 2021. Earlier roles include leadership positions at Smith & Nephew and various capacities within Johnson & Johnson, including a focus on sales leadership and market development. Phil holds an MBA in General Management and Strategy from the University of Michigan and a Bachelor of Science degree from Penn State University.